Common questions about Diclo-Vision (FAQ)
Q: Is Diclo-Vision the same type of medicine as other anti-inflammatory eye drops?
No, Diclo-Vision is classified as an NSAID (Nonsteroidal Anti-Inflammatory Drug) for eye use. This classification means it works differently than topical corticosteroids, which are also used for eye inflammation but belong to the steroid drug class.
Q: Are there any known interactions between Diclo-Vision and eye drops for glaucoma?
Official documents do not list specific drug-drug interaction warnings with common glaucoma medications. However, a mandatory interval of at least five minutes is required between applying Diclo-Vision and any other topical eye drop. This rule helps ensure that neither medication washes out the other.
Q: What is the difference between Diclo-Vision and a pain killer taken by mouth?
Diclo-Vision is a topical solution applied directly to the eye, where it acts locally to reduce inflammation and pain on the surface of the eye. Official studies show that the amount of the drug that reaches the bloodstream (systemic absorption) is very low when used as directed. This low systemic exposure contrasts with pain relief medicines taken by mouth.
Q: What are the ingredients in Diclo-Vision besides the main active drug?
Besides the active ingredient, Diclofenac Sodium, the product contains inactive ingredients (excipients). These typically include a preservative to maintain sterility, along with buffering agents to help the solution match the eye’s natural environment.
Q: How quickly do the effects of Diclo-Vision start?
Official labels do not specify a precise time for the onset of action. However, clinical studies found that pain and light sensitivity relief was measured starting within the first six hours following surgery for corneal procedures.
Q: Can Diclo-Vision be used for eye redness not related to surgery?
No, the official product indications are limited to treating postoperative inflammation (swelling) after cataract surgery and for temporary relief of pain after corneal refractive surgery (PRK). Regulatory documents do not support its use for eye redness or inflammation unrelated to these specific procedures.
Q: Can I use Diclo-Vision if I wear contact lenses?
Regulatory warnings state that the use of soft contact lenses is generally avoided due to documented risks. Official administration guidelines recommend removing lenses prior to application, except for the specific use of a bandage soft contact lens after PRK.
Q: What happens if I miss a dose of Diclo-Vision?
Official administration instructions state that if a dose is missed, patients should continue with the next scheduled dose as planned. They also warn against applying a double dose to make up for the missed one.
Q: Do I need to shake the Diclo-Vision bottle before using it?
The product is described in regulatory documents as a sterile aqueous solution, not a suspension. Solutions generally do not require shaking, and there is no instruction to shake the bottle included in the official patient administration guidelines.
Q: Can Diclo-Vision affect my vision temporarily after I put in the drops?
Yes, regulatory documents list blurred vision or temporary changes in vision as a less common adverse effect. Official warnings state that caution should be used before driving or operating machinery until vision is completely clear.
Q: Can Diclo-Vision be used for allergic eye conditions?
No, the official indications for this product are strictly limited to the treatment of postoperative inflammation following cataract extraction and certain other surgical procedures. Use for allergic eye conditions is not included in the official regulatory documentation.
Q: Are there any specific activities to avoid while using Diclo-Vision?
Official guidelines address activities that require clear vision. Because temporary blurred vision is a reported side effect, official guidelines state that patients should not drive or operate machinery if they experience this effect until their vision returns to normal.
Q: Is Diclo-Vision known to cause dry eye symptoms?
Dry eye itself is not listed as a common side effect in the primary clinical trials. However, official warnings note that patients with pre-existing ocular surface disease, such as dry eye syndrome, may be at an increased risk of serious corneal adverse events.
Q: Is it safe to drive after using Diclo-Vision?
Since the medication can cause transient blurring of vision, official guidelines state that patients should not drive or operate machinery if affected. Official guidelines recommend waiting until vision is completely clear before engaging in these activities.
Q: Can I use Diclo-Vision if I have had a previous eye infection?
The anti-inflammatory properties of this medication may mask the signs or progression of an ocular infection. Official warnings note that if an infection is suspected or present, appropriate antibacterial therapy and close professional monitoring are required.
Q: Can Diclo-Vision cause a reaction on the skin around the eye?
The primary adverse effects reported are local, affecting the eye itself. Less common systemic reactions, such as facial edema (swelling), were reported in a small number of patients in clinical studies, which could potentially include swelling around the eye area.
Q: What should I do if my eye irritation seems worse after using the drops?
Official product warnings advise that patients who experience worsening symptoms, changes in vision, or any signs of a serious adverse event (like corneal damage) should immediately discontinue use. Official patient information states that professional consultation is required without delay if this occurs.
Q: Can I share my Diclo-Vision with another person?
To prevent contamination that could lead to serious eye damage, patients are instructed not to touch the tip of the applicator bottle to any surface. Sharing the bottle with another person risks contamination, and official guidelines are focused on preventing this by instructing that the bottle tip must not touch any surface.
Q: Can I use Diclo-Vision if I am breastfeeding?
Studies on oral diclofenac show that it is excreted into human milk in small amounts. Due to the very low systemic absorption of the eye drop solution, official documents state that adverse effects in the breastfed infant are not expected. However, caution should still be exercised.
Q: Does the concentration of Diclo-Vision matter?
The official product is formulated at a concentration of 0.1% (1 mg/mL). Official information is based entirely on the safety and efficacy of this specific formulation. Regulatory documents do not provide information comparing the product with other concentrations.
Q: Is Diclo-Vision used to prevent swelling or treat existing swelling?
The drug is officially indicated for the treatment of postoperative inflammation (swelling) and pain relief. For cataract surgery, the dosing typically begins after the procedure, which generally occurs in a therapeutic setting. However, for PRK procedures, dosing can sometimes begin pre-operatively, which suggests a prophylactic role.
